Therapeutic approaches for SARS-CoV-2 infection

Therapeutic approaches to COVID-19 treatment require appropriate inhibitors to target crucial proteins of SARS-CoV-2 replication machinery. It’s been approximately 12 months since the pandemic started, yet no known specific drugs are available. However, research progresses with time in terms of high...

Descripción completa

Detalles Bibliográficos
Autores principales: Gupta, Ankur, Pradhan, Anish, Maurya, Vimal K., Kumar, Swatantra, Theengh, Angila, Puri, Bipin, Saxena, Shailendra K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096528/
https://www.ncbi.nlm.nih.gov/pubmed/33962011
http://dx.doi.org/10.1016/j.ymeth.2021.04.026

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096528/
https://www.ncbi.nlm.nih.gov/pubmed/33962011
http://dx.doi.org/10.1016/j.ymeth.2021.04.026

Ejemplares similares